Letter from CDC (Drug Resistant Streptococcus pneumoniae Therapeutic Working Group)
“Since clinical-only studies would need to be prohibitively large to detect a difference if one truly existed between two drugs and their respective pathogen-directed efficacies, the committee believes a smaller bacteriologically-driven study would be more effective, especially since bacteriologic failure is correlated with clinical failure.”